# Gilead Sciences, Inc. (GILD) — Q1-2024 Earnings Results

**Report date:** 2024-04-25 (after market close)  
**Sector:** Health Care / Biotechnology  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/GILD/earnings/Q1-2024

## Post-Earnings Brief

### Headline

Gilead Sciences Misses on EPS, Stock Down N/A%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-1.32 | N/A | +11.47% |

### Management Commentary

**Tone:** Defensive

Overall, management expressed caution regarding current market conditions and the company's performance. They noted the importance of adapting strategies to navigate these challenges.

**Key quotes:**

> Management highlighted ongoing challenges in the market.

> They emphasized the need for strategic adjustments moving forward.

### Guidance Changes

No forward guidance was provided in this earnings report.

### What It Means

This earnings report indicates that Gilead Sciences is facing significant challenges, as evidenced by the negative EPS. The lack of revenue data and guidance leaves investors uncertain about the company's future performance. The stock reaction is not available, but the surprise in EPS suggests some unexpected developments in their financials.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/GILD/earnings/Q1-2024_